Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Med Sci Sports Exerc. 2018 Sep;50(9):1757–1766. doi: 10.1249/MSS.0000000000001641

Table 2.

Outcome Measures by Group over Timea

% ASC methylation
Mean (SD)
IL-1β (pg/mL)
Mean (SD)
IL-18 (pg/mL)
Mean (SD)
6MWT (meters)
Mean (SD)
Peak V̇O2 (ml/kg/min)
Mean (SD)
Baseline
 Control 5.75 (0.6) 1.88 (1.0) 162.67 (62.1) 330.97 (84.8) 15.75 (4.3)
 Exercise 5.88 (0.9) 1.65 (0.8) 149.90 (33.8) 351.97 (73.5) 17.31 (5.2)
3 Months
 Control 5.80 (0.4) 2.09 (1.3) 162.86 (66.8) 324.31 (137.3) 16.16 (6.3)
 Exercise 6.10 (0.5)* 1.43 (0.5)* 138.18 (56.0) 372.22 (64.5)* 16.61 (4.2)
6 Months
 Control 5.82 (0.4) 2.13 (1.4) 160.58 (34.7) 324.29 (128.3) --
 Exercise 6.07 (0.4)* 1.49 (0.5)*§ 130.15 (52.9) 387.33 (56.2)* --
a

PROC MIXED with least squares mean analysis adjusting with Bonferroni was used to compare within GROUP and between GROUP changes across TIME.

*

Group differences significant at p<.05.

Difference from baseline is significant at p<.01.

Difference from baseline significant at p<.05.

§

Difference from 3 months significant at p<.05.

ASC – Apoptosis associated speck-like protein containing a caspase recruitment domain

IL - Interleukin

6MWT – Six-minute walk test